The covariates that accounted for 50% of the variance in hs-CRP levelsincluded PCI>3 months, use of ACE inhibitors, hypolipidemic agents, anddyslipidemia in the CAD-T group (p<0.05). The gene discussed is ACE; the disease is coronary artery disorder.